The news comes after the company’s flagship Galaxy System, a lung nodule diagnostic tool, received FDA clearance.
The company will use the funding round to meet rising demand for the Galaxy System, according to an April 19 Noah Medical news release.
Softbank Vision Fund led the financing round.